STOCK TITAN
  1. Home
  2. Sec-filings
  3. ROIV
  4. [Form 4] Roivant Sciences Ltd. Insider Trading Activity

Roivant Sciences (ROIV) grants CAO new RSUs and stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Roivant Sciences Ltd. reported a compensation-related equity grant to Chief Accounting Officer Jennifer Humes. She received 29,173 Common Share RSUs, bringing her direct Common Share holdings to 113,364 shares after the award.

Humes was also granted 27,157 stock options to buy Common Shares at an exercise price of $29.08 per share, expiring on April 19, 2036. Both the RSUs and options have a vesting commencement date of April 20, 2026 and vest over time, subject to her continuous service with the company.

Positive

  • None.

Negative

  • None.
Insider Humes Jennifer
Role Chief Accounting Officer
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 27,157 $0.00 --
Grant/Award Common Shares 29,173 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 27,157 shares (Direct, null); Common Shares — 113,364 shares (Direct, null)
Footnotes (1)
  1. Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2026. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through each applicable vesting date. Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2026. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through each applicable vesting date.
RSUs granted 29,173 Common Shares Restricted stock units awarded to CAO on April 20, 2026
Options granted 27,157 options Stock options on Common Shares granted to CAO
Option exercise price $29.08 per share Exercise price for newly granted stock options
Shares held after grant 113,364 Common Shares Direct Common Share holdings following RSU award
Option expiration date April 19, 2036 Expiration of newly granted stock options
Vesting start date April 20, 2026 Vesting commencement date for RSUs and options
restricted stock units financial
"Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2026."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter..."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
stock options financial
"Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2026."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vesting commencement date financial
"with a vesting commencement date of April 20, 2026."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Common Shares financial
"Reflects an award of restricted stock units with respect to Common Shares ("RSUs")..."
Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Humes Jennifer
(Last)(First)(Middle)
C/O ROIVANT SCIENCES LTD.
7TH FLOOR, 50 BROADWAY
(Street)
LONDONSW1H 0DB
(City)(State)(Zip)
UNITED KINGDOM
(Country)		2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares04/20/2026A29,173(1)A$0113,364D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$29.0804/20/2026A27,157 (2)04/19/2036Common Shares27,157$027,157D
Explanation of Responses:
1. Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2026. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through each applicable vesting date.
2. Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2026. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through each applicable vesting date.
Remarks:
/s/ Jo Chen, as Attorney-in-Fact for Jennifer Humes04/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Roivant Sciences (ROIV) grant to Jennifer Humes?

Roivant Sciences granted Chief Accounting Officer Jennifer Humes 29,173 RSUs and 27,157 stock options on Common Shares. These awards are part of her equity compensation and vest over time, subject to her continued service with the company.

How many Roivant Sciences (ROIV) shares does Jennifer Humes hold after this Form 4?

After the RSU award, Jennifer Humes directly holds 113,364 Common Shares of Roivant Sciences. This figure reflects her updated ownership position as reported in the Form 4 following the April 20, 2026 equity grants.

What is the exercise price of Jennifer Humes’ new Roivant Sciences (ROIV) stock options?

The newly granted stock options to Jennifer Humes have an exercise price of $29.08 per Common Share. She can purchase shares at this fixed price once the options vest and before they expire, subject to the vesting schedule and her ongoing service.

When do Jennifer Humes’ RSUs from Roivant Sciences (ROIV) vest?

The RSUs granted to Jennifer Humes start vesting from a April 20, 2026 commencement date. 25% vest on the first anniversary, with the remaining RSUs vesting in twelve equal quarterly installments, assuming she remains in continuous service.

What is the vesting schedule for Jennifer Humes’ new Roivant Sciences (ROIV) stock options?

Her options begin vesting from a April 20, 2026 commencement date. 25% vest and become exercisable on the first anniversary, with the remaining options vesting in 36 equal monthly installments, contingent on her continuous service with Roivant.

When do Jennifer Humes’ Roivant Sciences (ROIV) stock options expire?

The stock options granted to Jennifer Humes expire on April 19, 2036. She may exercise vested options any time before this expiration date, subject to the plan terms and her ongoing service with the company.